A new approach has been proposed to suppress the side effects of messenger ribonucleic acid (mRNA), opening up possibilities ...

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer ...

A joint Singaporean-Chinese research team has developed an Evans Blue-modified lipid nanoparticle platform that directs mRNA ...

Spatial RNA medicine combines transcriptomics and RNA therapeutics, mapping gene expression in tissues to enhance precision ...

Tattoo ink doesn’t just stay in the skin. New research shows it rushes into the lymphatic system, where it can persist for months, kill immune cells, and even disrupt how the body responds to ...

Everest Medicines has dosed the first participant in a Phase I clinical trial of its tumour-associated antigen (TAA) cancer vaccine EVM14 injection at the NEXT Oncology Virginia site in the US. The ...

LG Energy Solution said on the 8th that it signed a contract to supply electric-vehicle batteries to Mercedes-Benz (hereafter ...

Last year, the survival rate for patients with acute cardiac arrest in South Korea reached an all-time high of 9.2% since records began. The Korea Disease Control and Prevention Agency (KDCA) and th ...

Meta is scrambling to find a “solution” to its Messenger app being unintentionally included in the teen social media ban, in spite of the government’s promise it would be exempt. A seemingly ...

Samsung Biologics is set to expand its CDMO (Contract Development and Manufacturing Organization) modality portfolio by establishing its 3rd ...

For the first time, a drug to treat adult patients with familial chylomicronemia syndrome (FCS), a severe and rare condition ...